News Ypsomed Holding AG

Equities

YPSN

CH0019396990

Market Closed - Swiss Exchange Other stock markets 11:30:38 2024-04-18 am EDT			5-day change	1st Jan Change
380 ^CHF	+2.15%		+1.33%	+25.41%

Apr. 16	Ypsomed Partners with ten23 health for Wearable Injector Product Commercialization	MT
Apr. 12	Dental Equipment Company Straumann Names New Chair	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ypsomed Partners with ten23 health for Wearable Injector Product Commercialization	Apr. 16	MT
Ypsomed : and ten23 health collaborate for the commercialization of the YpsoDose patch injector	Apr. 16	PU
Dental Equipment Company Straumann Names New Chair	Apr. 12	MT
Gerresheimer expects sales boost from burgeoning obesity drugs sector	Apr. 11	RE
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says	Mar. 29	RE
MTD ACQUIRES YPSOMED'S PEN NEEDLE AND BGM BUSINESSES, STRENGTHENING ITS LEADING POSITION IN DIABETES CARE	Mar. 28	AQ
Swiss Equities Rise as Economic Sentiment Further Brightens	Mar. 27	MT
Ypsomed to Sell Pen Needle, Glucose Monitoring Units Amid Increased Focus on Diabetes Care	Mar. 27	MT
MTD Medical Technology and Devices S.A. agreed to acquire the Pen Needle and Blood Glucose Monitoring Businesses of Ypsomed Holding AG.	Mar. 26	CI
Octavian Downgrades Recommendation on Ypsomed to Hold From Buy	Feb. 26	MT
Switzerland's Sonova Names New Chair for 2025 Nomination	Nov. 17	MT
Ypsomed Holding AG Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 15	CI
Transcript : Ypsomed Holding AG, H1 2024 Earnings Call, Nov 15, 2023	Nov. 15
Ypsomed : Präsentation der Halbjahreszahlen 2023/24 (5,7 MiB)	Nov. 15	PU
Ypsomed : Presentation of Half-Year Results 2023/24 (5.7 MiB)	Nov. 15	PU
Ypsomed Posts Growth in Fiscal H1 Net Profit, Sales	Nov. 15	MT
Ypsomed : Financial key figures half-year 2023/24	Nov. 15	PU
Ypsomed : doubles profits and confirms outlook	Nov. 15	PU
How Novo Nordisk makes its weight-loss drug Wegovy	Nov. 01	RE
Ypsomed to Customize, Supply Autoinjector Pen Device for Viridian Therapeutics	23-10-26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ypsomed Holding AG

Equities

YPSN

CH0019396990

Summary

Filters